Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 May 2009):

Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.

Full Abstract

BACKGROUND: The authors elucidated particular chemokine receptors that are expressed on lung cancer cells, as well as the clinical significance of the expression of these chemokine receptors in completely resected nonsmall cell lung cancer (NSCLC). METHODS: The authors examined gene expression of chemokine receptors (CCR1-11, CXCR1-7, XCR1, and CX3CR1) in 11 cell lines of lung cancer, and gene expression of CXCR3, CXCR4, and CXCR7 (CXCR3/4/7) in surgical specimens of 127 patients who underwent complete resection for their NSCLC between May 2001 and December 2002, using quantitative real-time reverse transcriptase-polymerase chain reaction (PCR). Mutation detection analysis of the EGFR genes using the PCR single-strand conformational polymorphism method was evaluated in patients with pathological (p-) stage I adenocarcinoma. RESULTS: Substantial expression of CXCR3/4/7 mRNA was observed in all NSCLC cell lines examined. In p-stage I NSCLC, CXCR4 and CXCR7 expression values in patients with postoperative metastatic recurrence (Rec-Distant) were significantly higher than in those without recurrences (P = .003 and P = .007, respectively). In addition, the 5-year disease-free survival (DFS) rate of high CXCR7-expressing patients (63.2%) was significantly lower than that of low CXCR7-expressing patients (84.8%) (P = .033). The EGFR mutation was significantly more frequent in patients with higher CXCR7 expression (14 of 21 patients) than in those with lower CXCR7 expression (12 of 32 patients) (P = .038). A multivariate analysis confirmed that high CXCR7 expression was an independent and significant factor predicting a poor DFS in p-stage I NSCLC patients (P = .041). CONCLUSIONS: Higher expression of CXCR7 is associated with Rec-Distant and poor DFS in patients with p-stage I NSCLC. (c) 2009 American Cancer Society.

 

Author information

Author/s: Iwakiri, Shotaro (S); Mino, Nobuya (N); Takahashi, Tsuyoshi (T); Sonobe, Makoto (M); Nagai, Shinjiro (S); Okubo, Kenichi (K); Wada, Hiromi (H); Date, Hiroshi (H); Miyahara, Ryo (R);

Affiliation: Department of Thoracic Surgery, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.

Journal and publication information

Publication Type: Journal Article

Journal: Cancer (Cancer), published in United States. (Language: eng)

Reference: 2009-Jun; vol 115 (issue 11) : pp 2580-93

Dates: Created 2009/05/25; Completed 2009/07/16;

PMID: 19309748, status: MEDLINE (last retrieval date: 7/25/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: CXCR7 protein, human (0) ; Receptors, CXCR (0) ; Receptors, CXCR4 (0) ; Tumor Markers, Biological (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

5/30/2000
10/21/2008
Higher Relevance Score (100)
Lower Relevance Score (77)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index